Welcome to LookChem.com Sign In|Join Free
  • or
4,4'-Dihydroxy-biphenyl-2-carboxylic acid, a chemical compound with the molecular formula C14H10O5, is a derivative of biphenyl featuring two hydroxyl groups and a carboxylic acid group attached to the phenyl rings. It serves as a versatile building block in organic chemistry, often utilized in the synthesis of pharmaceuticals, agrochemicals, and materials for industrial applications. Additionally, it has been studied for its antioxidant properties and potential health benefits.

53197-57-2

Post Buying Request

53197-57-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53197-57-2 Usage

Uses

Used in Pharmaceutical Industry:
4,4'-Dihydroxy-biphenyl-2-carboxylic acid is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 4,4'-Dihydroxy-biphenyl-2-carboxylic acid is employed as a precursor in the production of agrochemicals, contributing to the development of effective pesticides and other agricultural chemicals.
Used in Industrial Material Production:
4,4'-DIHYDROXY-BIPHENYL-2-CARBOXYLIC ACID is utilized as a building block for the creation of various industrial materials, such as polymers and composites, due to its chemical properties and reactivity.
Used in Antioxidant Applications:
4,4'-Dihydroxy-biphenyl-2-carboxylic acid is studied for its antioxidant properties, which may have potential health benefits and applications in various industries, including food and cosmetics, to prevent oxidation and extend shelf life.
The production of 4,4'-Dihydroxy-biphenyl-2-carboxylic acid is typically achieved through synthetic organic chemistry methods, highlighting its importance as an intermediate in the production of a wide range of chemical compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 53197-57-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,1,9 and 7 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 53197-57:
(7*5)+(6*3)+(5*1)+(4*9)+(3*7)+(2*5)+(1*7)=132
132 % 10 = 2
So 53197-57-2 is a valid CAS Registry Number.

53197-57-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,4'-DIHYDROXY-BIPHENYL-2-CARBOXYLIC ACID

1.2 Other means of identification

Product number -
Other names 4,4'-Dioxydiphenylcarbon-2-saeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53197-57-2 SDS

53197-57-2Relevant academic research and scientific papers

An effective synthesis method for tilorone dihydrochloride with obvious IFN-α inducing activity

Zhang, Junren,Yao, Qizheng,Liu, Zuliang,De Sousa, Maria Emília

, p. 21458 - 21463 (2016/01/25)

Tilorone dihydrochloride (1) has great potential for inducing interferon against pathogenic infection. In this paper, we describe a convenient preparation method for 2,7-dihydroxyfluoren-9-one (2), which is a usual pharmaceutical intermediate for preparing tilorone dihydrochloride (1). In the novel method, methyl esterification of 4,4′-dihydroxy-[1,1′-biphenyl]-2-carboxylic acid (4) was carried out under milder conditions with higher yield and played an important role in the preparation of compound 2. The structures of the relative intermediates and target compound were characterized by melting point, IR, MS, and 1H-NMR. Furthermore, the synthesized tilorone dihydrochloride exhibited an obvious effect on induction of interferon-α (IFN-α) in mice within 12 h, and the peak level was observed until 24 h. This fruitful work has resulted in tilorone dihydrochloride becoming available in large-scale and wide application in clinics, which has a good pharmaceutical development prospects.

Photodecaging from 9-substituted 2,7-dihydroxy and dimethoxyfluorenes: Competition between heterolytic and homolytic pathways

Roxin, Aron,Chase, Alex,Jeffers, Elizabeth,Lukeman, Matthew

, p. 920 - 930 (2012/03/08)

2,7-Dihydroxy-9-fluorenol (9), 2,7-dimethoxy-9-fluorenol (10), and 2,7-dimethoxy-9-acetoxyfluorene (11) were prepared and their photochemistry was studied in methanol and aqueous methanol solution in the hopes of observing efficient expulsion of the substituents positioned at the 9-position. For all three compounds, the primary photoproducts were 2,7-disubstituted-9-fluorenes and 2,7-disubstituted-9-methoxyfluorenes. A mechanism of reaction is proposed for production of these products, and involves competing homolytic and heterolytic pathways that produce radical and carbocation intermediates. Reaction quantum yields (for substrate disappearance) ranged between 0.21 and 0.31.

Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]- propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides

Epperson, James R.,Bruce, Marc A.,Catt, John D.,Deskus, Jeffrey A.,Hodges, Donald B.,Karageorge, George N.,Keavy, Daniel J.,Mahle, Cathy D.,Mattson, Ronald J.,Ortiz, Astrid A.,Parker, Michael F.,Takaki, Katherine S.,Watson, Brett T.,Yevich, Joseph P.

, p. 4601 - 4611 (2007/10/03)

Compound 2b demonstrated full agonism at both human MT1 and MT2 receptors and demonstrated chronobiotic activity in both acute and chronic rat models, producing an acute phase advance of 32 min at 1 mg/kg and chronically entraining free-running rats with a mean effective dose of 0.23 mg/kg. This compound was significantly less efficacious than melatonin in constricting human coronary artery. A series of fluoren-9-yl ethyl amides (2) were synthesized and evaluated for human melatonin MT1 and MT 2 receptor binding. N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]propanamide (2b) was selected and evaluated in functional assays measuring intrinsic activity at the human MT1 and MT2 receptors and demonstrated full agonism at both receptors. The chronobiotic properties of 2b were demonstrated in both acute and chronic rat models where 2b produced an acute phase advance of 32 min at 1 mg/kg and chronically entrained free-running rats with a mean effective dose of 0.23 mg/kg. Compound 2b is significantly less efficacious than melatonin in constricting human coronary artery.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 53197-57-2